✦ LIBER ✦

Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration: Twelve-month MONT BLANC Study Results

✍ Scribed by Michael Larsen; Ursula Schmidt-Erfurth; Paolo Lanzetta; Sebastian Wolf; Christian Simader; Erika Tokaji; Stefan Pilz; Annemarie Weisberger

Book ID: 116806582
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 846 KB
Volume: 119
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2012.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subfoveal Choroidal Thickness after Rani

Subfoveal Choroidal Thickness after Ranibizumab Therapy for Neovascular Age-related Macular Degeneration: 12-Month Results

✍ Taizo Yamazaki; Hideki Koizumi; Tetsuya Yamagishi; Shigeru Kinoshita 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 519 KB

Ranibizumab versus Verteporfin Photodyna

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

✍ David M. Brown; Mark Michels; Peter K. Kaiser; Jeffrey S. Heier; Judy P. Sy; Tso 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Intravitreal bevacizumab (Avastin) in co

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study)

✍ Rogério A. Costa; Rodrigo Jorge; Daniela Calucci; Luiz A. S. Melo; José A. Cardi 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Verteporfin therapy of subfoveal choroid

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension

✍ Peter K. Kaiser; Treatment of Age-related Macular Degeneration with Photodynamic 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 287 KB

Photodynamic therapy with verteporfin in

Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): Results of the Japanese AMD Trial (JAT) extension

✍ Japanese Age-Related Macular Degeneration Trial (JAT) Study Group; Masahito Ohji 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 362 KB

Comparing outcomes in patients with subf

Comparing outcomes in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration treated with two different doses of primary intravitreal bevacizumab: results of the pan-american collaborative retina study group (PACORES) at the 12-month follow-up

✍ Lihteh Wu; J. Fernando Arevalo; Mauricio Maia; Maria H. Berrocal; Juan Sanchez; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 122 KB